Amarin Corporation plc (AMRN)

0.7200 +0.0160 (+2.27%) At close: 04:00PM EST

Amarin Corporation plc

Iconic Offices, The Greenway
Block C Ardilaun Court St Stephens Green
Dublin 112-114
Ireland
353 0 166 99020
https://www.amarincorp.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full Time Employees: 365

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Thomas Charles Reilly	Chief Financial Officer	856.49k	N/A	1972
Dr. Steven B. Ketchum Ph.D.	President of Research & Development and Chief Scientific Officer	991.19k	N/A	1965
Mr. Aaron D. Berg	Executive VP & President of U.S.	913.7k	N/A	1963
Mr. Patrick Holt	President, CEO & Director	N/A	N/A	N/A
Mr. Jordan Zwick	Senior VP of Corporate Business Development & Investor Relations	N/A	N/A	1987
Mr. Jonathan N. Provoost	Executive VP and Chief Legal & Compliance Officer	N/A	N/A	N/A
Ms. Donna Pasek	Senior Vice President of Human Resources	N/A	N/A	N/A
Mr. Laurent Abuaf	President of Europe & Senior VP	N/A	N/A	N/A
Dr. Nabil Abadir	Chief Medical Officer of Global Medical Affairs	N/A	N/A	N/A
Dr. David Keenan Ph.D.	Executive VP of Technical Operations & President of Europe	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate Governance

Amarin Corporation plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.